Good article to read! RT @jitcancer #JITC Review: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy) https://t.co/gvbHPaOKS1
RT @jitcancer: #JITC Review: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Napl…
RT @jitcancer: #JITC Review: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Napl…
#JITC Review: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy) https://t.co/GCCGrHYlnL https://t.co/d1L5e3LtiP
RT @jitcancer: New #JITC Review: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018,…
RT @jitcancer: New #JITC Review: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018,…
RT @jitcancer: New #JITC Review: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018,…
New #JITC Review: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy) https://t.co/GCCGrHGKwd @PAscierto https://t.co/r3zIYaEjgR
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy). https://t.co/qTi9v3jQAJ
New article: Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy). https://t.co/sgzugMhyHw #melanoma #oncology